{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:46:33Z","timestamp":1780983993087,"version":"3.54.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009071","name":"Colgate University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R15DA057501 - 01A1"],"award-info":[{"award-number":["1R15DA057501 - 01A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neuropharm.2024.109947","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T21:34:35Z","timestamp":1713216875000},"page":"109947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["\u03b2-caryophyllene inhibits heroin self-administration, but does not alter opioid-induced antinociception in rodents"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-4378","authenticated-orcid":false,"given":"Ewa","family":"Galaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-8104","authenticated-orcid":false,"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.109947_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2014.06.025","article-title":"The cannabinoid receptor 2 agonist, \u03b2-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice","volume":"124","author":"Al Mansouri","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.109947_bib2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/ph16101426","article-title":"Evaluating sex differences in efficacy, safety and pharmacokinetics in patients treated with cannabis by a metered-dose inhaler","volume":"16","author":"Aviram","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2024.109947_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","article-title":"\u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice","volume":"135","author":"Bahi","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2024.109947_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(99)00389-1","article-title":"Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the Guinea-pig ileum myenteric plexus","volume":"376","author":"Basilico","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib5","first-page":"6","article-title":"Interactions of the opioid and cannabinoid systems in reward: insights from knockout studies","volume":"6","author":"Befort","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","article-title":"\u03b2-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPAR\u03b3 pathway","volume":"178","author":"Bento","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106560","article-title":"Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy","volume":"187","author":"Carey","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2024.109947_bib9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fnins.2020.00850","article-title":"The CB2 agonist \u03b2-caryophyllene in male and female rats exposed to a model of persistent inflammatory pain","volume":"14","author":"Ceccarelli","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejphar.2015.08.001","article-title":"\u03b2-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways","volume":"764","author":"Cho","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.lfs.2006.11.038","article-title":"Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene","volume":"80","author":"Cho","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(24)38212-6","article-title":"Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification","volume":"289","author":"Cichewicz","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.109947_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/jpet.102.045575","article-title":"Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration","volume":"304","author":"Cichewicz","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.109947_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0028-3908(98)00195-6","article-title":"Repeated administration of delta9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat","volume":"38","author":"Corchero","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-016-4452-1","article-title":"Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents","volume":"234","author":"de Guglielmo","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib16","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1111\/bph.12851","article-title":"Analgesic tolerance to morphine is regulated by PPAR\u03b3","volume":"171","author":"de Guglielmo","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/npp.2014.268","article-title":"PPAR\u03b3 activation attenuates opioid consumption and modulates mesolimbic dopamine transmission","volume":"40","author":"de Guglielmo","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pbb.2005.01.031","article-title":"Endocannabinoid system and opioid addiction: behavioural aspects","volume":"81","author":"Fattore","year":"2005","journal-title":"Pharmacol. Biochem. Behav., Cannabinoids: Interact. Other Drugs"},{"key":"10.1016\/j.neuropharm.2024.109947_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(25)30692-0","article-title":"Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol","volume":"199","author":"Frederickson","year":"1976","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.109947_bib20","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41386-022-01379-1","article-title":"A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder","volume":"47","author":"Galaj","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib21","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41386-020-00885-4","article-title":"Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPAR\u03b1 and PPAR\u03b3: repurposing a FDA-approved food additive for cocaine use disorder","volume":"46","author":"Galaj","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms","volume":"167","author":"Galaj","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib23","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.0988-20.2020","article-title":"Dissecting the role of GABA neurons in the VTA versus SNr in opioid reward","volume":"40","author":"Galaj","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40263-019-00664-w","article-title":"Potential of cannabinoid receptor ligands as treatment for substance use disorders","volume":"33","author":"Galaj","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2024.109947_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/cib.1.1.6568","article-title":"Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action?","volume":"1","author":"Gertsch","year":"2008","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib26","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2024.109947_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pharep.2014.08.003","article-title":"Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex","volume":"67","author":"Ghavimi","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2024.109947_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","article-title":"Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors","volume":"22","author":"Ghozland","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.722476","article-title":"\u03b2-Caryophyllene, an FDA-approved food additive, inhibits methamphetamine-taking and methamphetamine-seeking behaviors possibly via CB2 and non-CB2 receptor mechanisms","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41401-018-0059-x","article-title":"Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats","volume":"40","author":"He","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2024.109947_bib31","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/bph.14969","article-title":"\u03b2-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents","volume":"177","author":"He","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02182-0","article-title":"PPAR\u03b1 and PPAR\u03b3 are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice","author":"Hempel","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109947_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1037\/pha0000188","article-title":"An assessment of concurrent cannabidiol and \u03949-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning","volume":"26","author":"Hempel","year":"2018","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2024.109947_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030675","article-title":"Role of \u03b2-caryophyllene in the antinociceptive and anti-inflammatory effects of Tagetes lucida cav. essential oil","volume":"25","author":"Hernandez-Leon","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.109947_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13005","article-title":"Optogenetic brain-stimulation reward: a new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice","volume":"26","author":"Humburg","year":"2021","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080326","article-title":"\u03b2-Caryophyllene mitigates collagen antibody induced arthritis (CAIA) in mice through a cross-talk between CB2 and PPAR-\u03b3 receptors","volume":"9","author":"Irrera","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2024.109947_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173544","article-title":"The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence","volume":"886","author":"Iyer","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/02791072.2018.1508789","article-title":"The PPAR\u03b3 agonist pioglitazone fails to alter the abuse potential of heroin, but does reduce heroin craving and anxiety","volume":"50","author":"Jones","year":"2018","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2024.109947_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.physbeh.2015.10.006","article-title":"The effects of pioglitazone, a PPAR\u03b3 receptor agonist, on the abuse liability of oxycodone among nondependent opioid users","volume":"159","author":"Jones","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2024.109947_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108241","article-title":"Xie 2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents","volume":"176","author":"Jordan","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2018.12.026","article-title":"Progress in brain cannabinoid CB2 receptor research: from genes to behavior","volume":"98","author":"Jordan","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.109947_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113622","article-title":"Mitochondrial biogenesis factor PGC-1\u03b1 suppresses spinal morphine tolerance by reducing mitochondrial superoxide","volume":"339","author":"Kashiwagi","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/j.1532-2149.2012.00242.x","article-title":"Involvement of peripheral cannabinoid and opioid receptors in \u03b2-caryophyllene-induced antinociception","volume":"17","author":"Katsuyama","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2024.109947_bib44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","article-title":"The cannabinoid CB\u2082 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain","volume":"24","author":"Klauke","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216104","article-title":"Beta-caryophyllene enhances wound healing through multiple routes","volume":"14","author":"Koyama","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.109947_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3940(01)01998-X","article-title":"Opioid, cannabinoid and vanilloid receptor localization on porcine cultured myenteric neurons","volume":"308","author":"Kulkarni-Narla","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2024.109947_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.118.113233","article-title":"Cannabinoid CB2 agonist AM1710 differentially suppresses distinct pathological pain states and attenuates morphine tolerance and withdrawal","volume":"95","author":"Li","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.117.109355","article-title":"Slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence","volume":"93","author":"Lin","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.113.204099","article-title":"Interactions between \u03bc-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration","volume":"345","author":"Maguire","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.109947_bib50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0091-3057(02)01041-9","article-title":"Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats","volume":"74","author":"Mar\u00edn","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.109947_bib51","first-page":"82","article-title":"Essential oil of Cannabis sativa L. strains","author":"Mediavilla","year":"1997","journal-title":"J. Int. Hemp. Assoc."},{"key":"10.1016\/j.neuropharm.2024.109947_bib52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0885-3924(97)00371-0","article-title":"Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats","volume":"15","author":"Megens","year":"1998","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.neuropharm.2024.109947_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bph.14856","article-title":"Lasting effects of repeated \u03949 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats","volume":"177","author":"Nguyen","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.yrtph.2017.12.013","article-title":"Non-clinical toxicity of \u03b2-caryophyllene, a dietary cannabinoid: absence of adverse effects in female Swiss mice","volume":"92","author":"Oliveira","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.phymed.2013.08.006","article-title":"The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice","volume":"21","author":"Paula-Freire","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2024.109947_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2004.08.023","article-title":"Nuclear receptor activation and interaction with morphine","volume":"157","author":"Royal","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108684","article-title":"Female but not male rats show biphasic effects of low doses of \u03949-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?","volume":"196","author":"Salviato","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib58","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1091581816655303","article-title":"Toxicological evaluation of \u03b2-caryophyllene oil: subchronic toxicity in rats","volume":"35","author":"Schmitt","year":"2016","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib59","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00213-018-4986-5","article-title":"Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder","volume":"235","author":"Schroeder","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib60","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2174\/1381612822666160311115226","article-title":"Polypharmacological properties and therapeutic potential of \u03b2-caryophyllene: a dietary phytocannabinoid of pharmaceutical promise","volume":"22","author":"Sharma","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2024.109947_bib61","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ph14121269","article-title":"Strain-, sex-, and time-dependent antidepressant-like effects of cannabidiol","volume":"14","author":"Silote","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2024.109947_bib62","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00000542-200105000-00029","article-title":"The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets","volume":"94","author":"Simoneau","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib63","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.3390\/cells11203262","article-title":"Neutral CB1 receptor antagonists as pharmacotherapies for substance use disorders: rationale, evidence, and challenge","volume":"11","author":"Soler-Cedeno","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.109947_bib64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel","article-title":"Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions","volume":"22","author":"Spanagel","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib65","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.109947_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116915","article-title":"\u03b2-Caryophyllene protects against ischemic stroke by promoting polarization of microglia toward M2 phenotype via the TLR4 pathway","volume":"237","author":"Tian","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib67","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1460-9568.2000.00929.x","article-title":"Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors","volume":"12","author":"Valverde","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib68","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bph.13722","article-title":"\u03b2\u2010Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice","volume":"175","author":"Varga","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib69","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(24)37642-6","article-title":"Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A","volume":"286","author":"Vivian","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.109947_bib70","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/pha0000135","article-title":"The effects of cannabidiol (CBD) on \u03949-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats","volume":"25","author":"Wakeford","year":"2017","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2024.109947_bib71","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/bph.14958","article-title":"Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: opposite roles of CB1\/CB2 versus GPR55 receptors","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib72","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13148-020-00993-4","article-title":"Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice","volume":"13","author":"Wanner","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.neuropharm.2024.109947_bib73","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2018.05.041","article-title":"Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys","volume":"833","author":"Weed","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109947_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110064","article-title":"Sex, species and age: effects of rodent demographics on the pharmacology of \u03949-tetrahydrocanabinol","volume":"106","author":"Wiley","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.109947_bib75","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2016.11.015","article-title":"The endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice","volume":"114","author":"Wilkerson","year":"2017","journal-title":"Neuropharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2024.109947_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0091-3057(80)80033-5","article-title":"Action of drugs of abuse on brain reward systems","volume":"13","author":"Wise","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.109947_bib77","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.bmcl.2014.04.112","article-title":"trans-Caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-\u03b1","volume":"24","author":"Wu","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2024.109947_bib78","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB\u2082 receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib79","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1301552","article-title":"Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats","volume":"33","author":"Xi","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109947_bib80","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fnins.2017.00583","article-title":"Neuroprotective effect of \u03b2-caryophyllene on cerebral ischemia-reperfusion injury via regulation of necroptotic neuronal death and inflammation: in vivo and in vitro","volume":"11","author":"Yang","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109947_bib81","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2016.07.047","article-title":"Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus","volume":"630","author":"Zhang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2024.109947_bib82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3892\/mmr.2022.12834","article-title":"Angiotensin II receptor type 1 blocker candesartan improves morphine tolerance by reducing morphine-induced inflammatory response and cellular activation of BV2 cells via the PPAR\u03b3\/AMPK signaling pathway","volume":"26","author":"Zhao","year":"2022","journal-title":"Mol. Med. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:28:32Z","timestamp":1778650112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":82,"alternative-id":["S0028390824001163"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109947","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-caryophyllene inhibits heroin self-administration, but does not alter opioid-induced antinociception in rodents","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109947"}}